Tag: October 14, 2024 revenue disclosure
Unlocking Tevogen Bio’s $1B+ Revenue Potential: Pipeline Portfolio Revealed (Oct 14, 2024)
Tevogen Bio, a biotech company focused on developing T cell therapeutics for infectious diseases and cancers, recently shared its projected $1B+ revenue potential, highlighting...